DFTX

Definium Therapeutics

• Dow Jones·1d ago

  Definium Therapeutics Initiated at Overweight by JP Morgan

• Dow Jones·1d ago

  Definium Therapeutics Price Target Announced at $84.00/Share by JP Morgan

• TipRanks·1d ago

  Definium Therapeutics initiated with an Overweight at JPMorgan

• Dow Jones·2d ago

  Definium Therapeutics Currently Down Eight Consecutive Days, on Pace for Longest Losing Streak Since January 2024 -- Data Talk

• TipRanks·3d ago

  Analysts’ Top Healthcare Picks: ArriVent BioPharma, Inc. (AVBP), Definium Therapeutics (DFTX)

• TipRanks·10/02 12:05

  Celcuity appoints Gryska to Board of Directors

• Simply Wall St·09/28 23:24

  Definium Therapeutics (DFTX) Stock Climbed, So What Is Behind The Fresh Attention?

• Simply Wall St·09/25 09:21

  Will Positive Phase 3 Anxiety Data Change Definium Therapeutics' (DFTX) Narrative

• NASDAQ·09/19 23:02

  Definium Therapeutics’ DT120 Hits Phase III Goals in Anxiety Study

• Simply Wall St·09/19 21:30

  Definium Therapeutics (DFTX) Posts Another Positive Phase 3, Is The Stock Still A Bargain?

• TipRanks·09/19 14:40

  Analysts Offer Insights on Healthcare Companies: Contineum Therapeutics, Inc. Class A (CTNM) and Definium Therapeutics (DFTX)

• Seeking Alpha·09/17 14:10

  10 mid-cap healthcare stocks with the strongest momentum grades

• TipRanks·09/17 13:55

  Psychedelic: Definium’s LSD-based drug meets endpoints in GAD study

• Seeking Alpha·09/17 13:45

  These mid-cap stocks have A+ momentum grades and over 100% YTD growth

• TipRanks·09/16 23:09

  Definium Therapeutics Set to Reveal Phase 3 Panorama Results for DT120 in Generalized Anxiety Disorder